| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.03 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.19 | 0.03 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.05 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.05 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |